Bay Area's PaxVax, Inc. Reels In Up To $60 Million in Financing
Clinuvel Snags A $95 Million Takeover Bid From New York-Based Retrophin, Inc. (RTRX)
AstraZeneca PLC (AZN) Taps Roche (RHHBY) For New Blood-Based Cancer Drug Tests
AstraZeneca PLC (AZN), QIAGEN N.V. (QGEN) Strike Lung Cancer Diagnostic Pact For Patients Suitable For Treatment With IRESSA
Merck & Co., Inc. (MRK) Cuts Another 600 Sales Reps
Bristol-Myers Squibb Company (BMY) Taps Bay Area's Redwood City For Expansion, Pharma Giant To Increase Workforce
Bruker Corporation Discloses Plans To Sell California Unit And Lay Off Up To 250 Staffers
Reckitt Benckiser Plc (RB.L) To Invest €100 Million In Its Consumer Health R&D Operations, Will Create 1,200 New Jobs
New Cambridge-Based Biotech VC Firm Remiges BioPharma Emerges, Eyes $150 Million Fund
GlaxoSmithKline (GSK) Seeks Approval For First Ever Malaria Vaccination
Amgen (AMGN), Bayer HealthCare (BAY)'s Nexavar Fails Late-Stage Breast Cancer Study
Massachusett's Ocular Therapeutix, Inc. (OCUL) Goes IPO At $13 A Share
Sources Reveal Reckitt Benckiser Plc (RB.L) Plans To Spinoff Virginia-Based Pharmaceutical Unit
Allegations Of GlaxoSmithKline (GSK) Corruption Spread To Syria
Kidney Dialysis Drug Phase 3 Data Boost Keryx Biopharmaceuticals (KERX)'s Hopes For U.S. Approval
Merck KGaA (MKGAF.PK) Eyes Southeast Asia Plants To Cut Costs
Merck KGaA (MKGAF.PK) To Begin Construction Of $108 Million China Plant
Incyte Corporation (INCY)'s Jakafi Fails to Provide RELIEF In Phase 3 Trial
See All News >
//-->